Literature DB >> 24905749

Emerging roles of microRNAs in chronic pain.

Atsushi Sakai1, Hidenori Suzuki2.   

Abstract

Chronic pain is a debilitating syndrome caused by a variety of disorders, and represents a major clinical problem because of the lack of adequate medication. In chronic pain, massive changes in gene expression are observed in a variety of cells, including neurons and glia, in the overall somatosensory system from the sensory ganglia to the higher central nervous system. The protein expressions of hundreds of genes are thought to be post-transcriptionally regulated by a single type of microRNA in a sequence-specific manner. Recently, critical roles of microRNAs in the pathophysiology of chronic pain have been emerging. Genome-wide screenings of microRNA expression changes have been reported in a variety of painful conditions, including peripheral nerve injury, inflammatory diseases, cancer and spinal cord injury. The data obtained suggest that a wide range of microRNAs change their expressions in individual pain conditions, although the pathological significance of individual microRNAs as causal mediators in distinct pain conditions remains to be revealed for a limited number of microRNAs. Insights into the roles of microRNAs in chronic pain will enhance our understanding of the pathophysiology of chronic pain and allow prompt therapeutic application of microRNA-related drugs against intractable persistent pain.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocyte; Cancer pain; Hyperexcitability; Inflammatory pain; Microglia; Neuroinflammation; Neuropathic pain; Primary sensory neuron; Spinal cord; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24905749     DOI: 10.1016/j.neuint.2014.05.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  20 in total

Review 1.  Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.

Authors:  Leonardo Fonseca Rodrigues; Vivaldo Moura-Neto; Tania Cristina Leite de Sampaio E Spohr
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

2.  Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies.

Authors:  W-S Shen; X-Q Xu; N-N Zhai; Z-S Zhou; J Shao; Y-H Yu
Journal:  Gene Ther       Date:  2017-04-25       Impact factor: 5.250

3.  miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation.

Authors:  Naomi Ito; Atsushi Sakai; Noriko Miyake; Motoyo Maruyama; Hirotoshi Iwasaki; Koichi Miyake; Takashi Okada; Atsuhiro Sakamoto; Hidenori Suzuki
Journal:  Br J Pharmacol       Date:  2017-01-23       Impact factor: 8.739

4.  Circulating microRNA Signatures in Rodent Models of Pain.

Authors:  Rehman A Qureshi; Yuzhen Tian; Marguerite K McDonald; Kathryn E Capasso; Sabrina R Douglas; Ruby Gao; Irina A Orlova; James E Barrett; Seena K Ajit; Ahmet Sacan
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

5.  MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Steven F Maier; Linda R Watkins
Journal:  Brain Res       Date:  2018-05-01       Impact factor: 3.252

6.  Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.

Authors:  Yi Tan; Jun Yang; Kai Xiang; Qindong Tan; Qulian Guo
Journal:  Neurochem Res       Date:  2014-12-09       Impact factor: 3.996

7.  MiR-155 modulates the progression of neuropathic pain through targeting SGK3.

Authors:  Shaoxing Liu; Bo Zhu; Yan Sun; Xianfeng Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

8.  Expression changes of microRNA-1 and its targets Connexin 43 and brain-derived neurotrophic factor in the peripheral nervous system of chronic neuropathic rats.

Authors:  Elena Neumann; Henning Hermanns; Franziska Barthel; Robert Werdehausen; Timo Brandenburger
Journal:  Mol Pain       Date:  2015-06-26       Impact factor: 3.395

Review 9.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

10.  An approach to identify microRNAs involved in neuropathic pain following a peripheral nerve injury.

Authors:  Monica Norcini; Alexandra Sideris; Lourdes A Martin Hernandez; Jin Zhang; Thomas J J Blanck; Esperanza Recio-Pinto
Journal:  Front Neurosci       Date:  2014-08-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.